SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    McFarlin DE, McFarland HF. Multiple Sclerosis. Part I. N Engl J Med 1982; 307:11838.
  • 2
    McFarlin DE, McFarland HF. Multiple Sclerosis. Part II. N Engl J Med 1982; 307:124651.
  • 3
    Segal BM, Raine CS, McFarlin DE, Voskuhl RR, McFarland HF. Experimental allergic encephalomyelitis by the peptide encoded by exon 2 of the MBP gene – a peptide implicated in remyelination. J Neuroimmunol 1994; 51:719.
  • 4
    Voskuhl RR, McFarlin DE, Stone R, McFarland HF. T lymphocyte recognition of a portion of myelin basic protein encoded by an exon expressed during myelination. J Neuroimmunol 1993; 42:18792.
  • 5
    Zamvil S, Nelson P, Trotter J et al. T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. Nature 1985; 317:3558.
  • 6
    Bielekova B, Goodwin BR, Ichert N et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand. Nature Med 2000; 6:116775.
  • 7
    Allegreta M, Nicklas JA, Sea S. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990; 247:71821.
  • 8
    Lovett-Racke AE, Trotter JL, Lauber J, Perrin PJ, June CH, Racke MK. Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. J Clin Invest 1998; 101:72530.
  • 9
    Ponsford M, Mazza G, Coad J, Campbell MJ, Zajicek J, Wraith DC. Differential responses of CD45+ve T cell subsets to MBP in multiple sclerosis. Clin Exp Immunol 2001; 124:31522.
  • 10
    Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990; 346:1837.
  • 11
    Valli A, Sette A, Kappos L et al. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J Clin Invest 1993; 91:61628.
  • 12
    Meinl E, Weber F, Drexler K et al. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. J Clin Invest 1993; 92:263343.
  • 13
    Salvetti M, Ristori G, D’Amato M et al. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis. Eur J Immunol 1993; 23:12329.
  • 14
    Kozovska M, Zang YCQ, Aebischer I et al. T cell recognition motifs of an immunodominant peptide of myelin basic protein in patients with multiple sclerosis: structural requirements and clinical implications. Eur J Immunol 1998; 28:1894901.DOI: 10.1002/(sici)1521-4141(199806)28:06<1894::aid-immu1894>3.3.co;2-n
  • 15
    Zang YCQ, Kozovska MM, Hong J et al. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur J Immunol 1999; 29:1692700.
  • 16
    Deibler GE, Martenson RE, Kies MW. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prepara Biochem 1972; 2:139.
  • 17
    Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis – guidelines for research protocols. Ann Neurol 1983; 13:22731.
  • 18
    Plebanski M, Burtles SS. In vitro primary responses of human T cells to soluble protein antigens. J Imm Meth 1994; 170:1525.
  • 19
    Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acid Res 1988; 16:1215.
  • 20
    Olerup O, Zetterquist H. HLA-DR typing by PCR amlification with sequence-specific primers (PRC-SSP) in 2 hours – an alternative to serological DR typing in clinical practice including donor recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39:22535.
  • 21
    Schreuder GMT, Hurley CK, Marsh SGE et al. The HLA dictionary 1999. Hum Immunol 1999; 60:115781.
  • 22
    Lisak RP, Zweiman B. In vitro cell-mediated immunity of cerebrospinal-fluid lymphocytes to myelin basic protein in primary demyelinating diseases. N Eng J Med 1977; 297:8503.
  • 23
    Vandenbark AA, Chou YK, Bourdette D et al. Human lymphocyte-T response to myelin basic-protein – selection of lymphocyte-T lines from MBP-responsive donors. J Neurosci Res 1989; 23:2130.
  • 24
    Johnson D, Hafler DA, Fallis RJ et al. Cell-mediated-immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic-protein in multiple-sclerosis. J Neuroimmunol 1986; 13:99108.
  • 25
    Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CC, Ben Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 1993; 92:26028.
  • 26
    Tejada-Simon MV, Hong J, Rivera VM, Zhang JZ. Reactivity pattern and cytokine profile of T, cells primed by myelin peptides in multiple sclerosis and healthy individuals. Eur J Immunol 2001; 31:90717.DOI: 10.1002/1521-4141(200103)31:3<907::aid-immu907>3.3.co;2-t
  • 27
    Greer JM, Csurhes PA, Cameron KD, McCombe PA, Good MF, Pender MP. Increased immunoreactivity to two overlapping peptides of myelin proteolipid protein in multiple sclerosis. Brain 1997; 120:144760.
  • 28
    Pette M, Fujita K, Wilkinson D et al. Myelin autoreactivity in multiple sclerosis: recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci USA 1990; 87:796872.
  • 29
    Bieganowska K, Ausubel LJ, Modabber Y, Slovik E, Messersmith W, Hafler DA. Direct ex vivo analysis of activated, Fas-Sensitive autoreactive T cells in human autoimmune disease. J Exp Med 1997; 185:158594.
  • 30
    Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel RP. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 1999; 189:103342.
  • 31
    Goebels N, Hofstetter H, Schmidt S, Brunner C, Wekerle H, Hohlfeld R. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects. Brain 2000; 123:50818.
  • 32
    Pender MP, Csurhes PA, Greer JM et al. Surges of increased T cell reactivity to encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects. J Immunol 2000; 165:532231.
  • 33
    Scholz C, Patton KT, Anderson DE, Freeman GJ, Hafler DA. Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation. J Immunol 1998; 160:15328.
  • 34
    Burns J, Batholomew B, Lobo S. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis. Ann Neurol 1999; 45:339.DOI: 10.1002/1531-8249(199901)45:1<33::aid-art7>3.3.co;2-7
  • 35
    Anderton SM, Wraith DC. Hierarchy in the ability of T cell epitopes to induce peripheral tolerance to antigens from myelin. Eur J Immunol 1998; 28:125161.DOI: 10.1002/(sici)1521-4141(199804)28:04<1251::aid-immu1251>3.3.co;2-f